Sten G. Eriksson

Sten G. Eriksson's AcademicInfluence.com Rankings

Sten G. Eriksson

Philosophy

#7211

World Rank

#10392

Historical Rank

Logic

#4276

World Rank

#5547

Historical Rank

philosophy Degrees

Sten G. Eriksson

Biology

#9794

World Rank

#13041

Historical Rank

Genetics

#1010

World Rank

#1108

Historical Rank

Molecular Biology

#1366

World Rank

#1393

Historical Rank

Biochemistry

#1509

World Rank

#1638

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Sten G. Eriksson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sten G. Eriksson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency (1963) (1343)
Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. (1986) (571)
PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY. (2009) (418)
Studies in alpha 1-antitrypsin deficiency. (1965) (386)
Liver disease in adults with alpha-1 -antitrypsin deficiency. (1972) (250)
Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency: Executive summary (2003) (235)
Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. (1997) (177)
The liver in adolescents with α‐antitrypsin deficiency (1995) (176)
The Electrophoretic α1-Globulin Pattern of Serum in α1-Antitrypsin Deficiency (2013) (157)
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. (1997) (155)
Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). (1999) (147)
Strong link between the alpha1‐antitrypsin PiZ allele and Wegener's granulomatosis (1994) (143)
Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). (1997) (130)
Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. (1995) (127)
The PiZ gene of α1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis (1995) (124)
Obstructive Lung Disease and Trypsin Inhibitors in α1-Antitrypsin Deficiency (1967) (117)
Endocrine cells in the human oxyntic mucosa. A histochemical study. (1988) (116)
Purification and Partial Characterization of PAS-Positive Inclusion Bodies from the Liver in Alpha1-Antitrypsin Deficiency (1975) (92)
Characterization of α1-Antitrypsin in the Inclusion Bodies from the Liver in α1-Antitrypsin Deficiency (1975) (91)
Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody. (1985) (91)
The molecular basis of α1-antichymotrypsin deficiency in a heterozygote with liver and lung disease (1993) (84)
Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ. (1988) (82)
B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. (1997) (82)
Detection of Circulating and Endothelial Cell Polymers of Z and Wild Type α1-Antitrypsin by a Monoclonal Antibody* (2002) (81)
The liver in adolescents with alpha 1-antitrypsin deficiency. (1995) (78)
Inhibition of Alzheimer β-Peptide Fibril Formation by Serum Amyloid P Component (*) (1995) (77)
Environmental correlates of impaired lung function in non-smokers with severe α1-antitrypsin deficiency (PiZZ) (1998) (75)
Ultrasonographic screening for gallstone disease in middle-aged women. Detection rate, symptoms, and biochemical features. (1985) (72)
A 30-Year Perspective on α1-Antitrypsin Deficiency (1996) (72)
Liver, lung and malignant disease in heterozygous (Pi MZ) alpha1-antitrypsin deficiency. (2009) (71)
Influence of Thyroid Activity on Excretion of Bile Acids and Cholesterol in the Rat.∗ † (1957) (69)
Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men. (1977) (68)
The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. (1995) (58)
Systemic necrotizing vasculitides in severe alpha1-antitrypsin deficiency. (1996) (55)
Monoclonal antibody specific for the mutant PiZ alpha 1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers. (1984) (55)
Long-term immunosuppressive treatment in Crohn's disease. (1985) (53)
Regional differences in the idiopathic hemochromatosis gene frequency in Sweden. (2009) (51)
The serum α1-antitrypsin in families with hypo-α1-antitrypsinemia (1965) (49)
The natural history of air-flow obstruction in PiZ emphysema. Report of an NHLBI workshop. (1983) (46)
Alpha 1-antitrypsin deficiency: lessons learned from the bedside to the gene and back again. Historic perspectives. (1989) (45)
Lung function studies in asymptomatic individuals with moderately (Pi SZ) and severely (Pi Z) reduced levels of alpha1-antitrypsin. (1976) (44)
Complexes between proteinase 3, α1‐antitrypsin and proteinase 3 anti‐neutrophil cytoplasm autoantibodies: a comparison between α1‐antitrypsin PiZ allele carriers and non‐carriers with Wegener's granulomatosis (1996) (41)
The prevalence and clinical significance of α1‐antitrypsin deficiency (PiZ) and anca specificities (proteinase 3, BPI) in patients with ulcerative colitis (1999) (41)
Analysis of Systemic Biomarkers in COPD Patients (2004) (41)
Alpha 1-antitrypsin deficiency and liver cirrhosis in adults. An analysis of 35 Swedish autopsied cases. (1987) (39)
Obstructive lung disease and trypsin inhibitors in alpha-1-antitrypsin deficiency. (1967) (37)
Alpha 1-antitrypsin and other acute phase reactants in liver disease. (2009) (37)
Is there a relationship between abdominal aortic aneurysms and alpha1-antitrypsin deficiency (PiZ)? (1999) (35)
Intra- and extracellular alpha 1-antitrypsin in liver disease with special reference to Pi phenotype. (1981) (35)
Serum isoamylases in chronic pancreatitis. (1976) (35)
A specific structural interaction of Alzheimer's peptide Aβ1–42 with α1-antichymotrypsin (1996) (34)
α1Antitrypsin Deficiency and Liver Cirrhosis in Adults (2009) (33)
Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function. (1985) (33)
Pulmonary function in middle-aged women with heterozygous deficiency of the serine protease inhibitor alpha 1-antichymotrypsin. (1990) (32)
A 30-year perspective on alpha 1-antitrypsin deficiency. (1996) (32)
Lack of relationship between cholecystectomy and colorectal cancer. A case control autopsy study in a defined population. (1984) (31)
The microheterogeneity of desialylated alpha 1-antichymotrypsin: the occurrence of two amino-terminal isoforms, one lacking a His-Pro dipeptide. (1989) (30)
Tuberculous Meningitis: Immune Reactions within the Central Nervous System (1981) (29)
Organ cultures of human fetal hepatocytes in the study of extra-and intracellular alpha1-antitrypsin. (1978) (28)
Prevalence and clinical significance of gliadin antibodies in healthy children and adults. (1994) (27)
Liver Disease in α1-Antitrypsin Deficiency: Aspects of Incidence and Prognosis (1985) (27)
In vitro fibril formation from alpha 1-antitrypsin-derived C-terminal peptides. (1995) (26)
Biosynthesis of Abnormally Glycosylated α‐Antitrypsin by a Human Hepatoma Cell Line (1984) (25)
The prevalence and clinical significance of alpha 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis. (1999) (24)
Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency. (1974) (24)
Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis. (1995) (23)
Fasting serum bile acids in liver disease. A comparison with histological features. (1982) (23)
A New Abnormal Serum Globulin alpha1-Antitrypsin. (1963) (22)
In vitro complex formation between cholesterol and α1‐proteinase inhibitor (1993) (20)
Short and long term course of elderly patients with peptic ulcer bleeding--analysis of factors influencing fatal outcome. (2003) (19)
Low density lipoprotein catabolism is enhanced by the cleaved form of alpha-1-antitrypsin. (1997) (19)
Partial deficiency of alpha 1-antichymotrypsin is associated with chronic cryptogenic liver disease. (1991) (19)
Hepatocyte inclusions of δ1‐antichymotrypsin in a patient with partial deficiency of δ1‐antichymotrypsin and chronic liver disease (1990) (19)
THE SERUM ALPHA-L-ANTITRYPSIN IN FAMILIES WITH HYPO-ALPHA-L-ANTITRYPSINEMIA. (1965) (19)
Omeprazole improves outcome in peptic ulcer bleeding (1995) (18)
CIRRHOSIS AND MALIGNANT HEPATOMA IN α1-ANTITRYPSIN DEFICIENCY (2009) (18)
Heterozygous alpha 1-antichymotrypsin and PiZ alpha 1-antitrypsin deficiency. Prevalence and clinical spectrum in asthmatic children. (1990) (18)
Nutritional Status and Muscle Strength in Patients with Emphysema and Severe α1-Antitrypsin Deficiency (2002) (18)
Ulcer healing and relapse prevention by ranitidine in peptic ulcer disease. (1985) (17)
Beneficial effects of I.V. omeprazole (OME) in patients with peptic ulcer bleeding (PUB) (1995) (17)
Other clinical studyThe liver in adolescents with α1-antitrypsin deficiency☆ (1995) (17)
Alpha 1-antitrypsin deficiency. (1998) (16)
Heterozygous α‐antichymotrypsin and PiZ (α1‐antitrypsin deficiency (1990) (16)
Liver disease in alpha 1-antitrypsin deficiency. Aspects of incidence and prognosis. (1985) (16)
Alpha1-antitrypsin deficiency may be a risk factor for duodenal ulcer in patients with Helicobacter pylori infection. (2000) (16)
Characterization of alpha1-antitrypsin in the inclusion bodies from the liver in alpha 1-antitrypsin deficiency. (1975) (15)
Bile Acid Pool in the Rat: Bile Acids and Steroids. 78. (1960) (15)
Nutritional status and muscle strength in patients with emphysema and severe alpha(1)-antitrypsin deficiency. (2002) (15)
The putative role of alpha‐1‐antitrypsin in the disaggregation of amyloid lambda fibrils (1995) (14)
Biosynthesis of abnormally glycosylated hepatoma secretory proteins in cell cultures (1985) (13)
Severe α1-antitrypsin deficiency and intracranial aneurysms (1994) (13)
Liver function in asymptomatic adult individuals with severe alpha1-antitrypsin deficiency (Pi Z). (1977) (13)
Immunochemical and functional properties of biliary alpha-1-antitrypsin. (1996) (13)
A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin. (1996) (12)
Replacement therapy in α1‐antitrypsin deficiency (1989) (12)
The effect of tamoxifen in intermediate alpha 1-antitrypsin deficiency associated with the phenotype PiSZ. (1983) (12)
Familial α1‐Antichymotrypsin Deficiency (2009) (11)
[HYPO-ALPHA-1-ANTITRYPSINEMIA]. (1964) (11)
In vitro responsiveness of human gastric carcinoma to pentagastrin. (1977) (11)
Replacement therapy in alpha 1-antitrypsin deficiency. (1989) (11)
The interaction of hydrophobic bile acids with the α1‐proteinase inhibitor (1994) (10)
Plasma α1antichymotrypsin in liver disease (1985) (10)
Abdominal aortic aneurysms and alpha 1-antitrypsin deficiency. (1994) (10)
PR3-ANCA-positive vasculitis (1995) (10)
In vitro amyloid fibril formation from alpha 1-antitrypsin. (1995) (9)
Severe alpha1-antitrypsin deficiency (PiZ homozygosity) with membranoproliferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantation. (1997) (9)
4 α1-Antitrypsin deficiency (1998) (9)
Lack of Association between Hemochromatosis and α‐Antitrypsin Deficiency (2009) (9)
Emphysema Before and After 1963 (1991) (9)
Discovery of alpha 1-antitrypsin deficiency. (1990) (9)
Henoch-Schönlein purpura and alpha 1-antitrypsin deficiency. (1995) (9)
Prevalence of hemochromatosis. (1988) (8)
A Swedish family with alpha 1-antitrypsin deficiency, haemochromatosis, haemoglobinopathy D and early death in liver cirrhosis. (1986) (8)
Discovery ofα1-antitrypsin deficiency (1990) (8)
Alpha 1-antitrypsin deficiency: some personal experiences. (1984) (8)
Conformational changes of the α1‐proteinase inhibitor affecting its cholesterol binding ability (1993) (8)
Wegener's granulomatosis in a patient with severe PiZZ α1-antitrypsin deficiency (1996) (8)
Alpha 1-antitrypsin deficiency. (1999) (7)
Familial alpha 1-antichymotrypsin deficiency. (1986) (7)
Liver disease and intermediate alpha 1-antitrypsin deficiency. (1981) (7)
In vitro complex formation between cholesterol and alpha 1-proteinase inhibitor. (1993) (7)
Biliary Excretion of Cholesterol and Bile Acids in Bile Fistula Rats. (1956) (7)
Letter: EB-virus-seropostivie person is susceptible to infectious mononucleosis. (1975) (7)
Severe alpha 1-antitrypsin deficiency and intracranial aneurysms. (1994) (6)
Thein VitroEffect of Lithocholic Acid on the Polymerization Properties of PiZ Alpha-1-Antitrypsin (1998) (6)
The serum sialyltransferase activity in α1-antitrypsin deficiency (1976) (6)
Quantitive Determination of Bile Acids on Paper Chromatograms. (1954) (5)
Purification and partial characterization of pas-positive inclusion bodies from the liver in alpha 1-antitrypsin deficiency. (1975) (5)
Alpha1 ‐antitrypsin deficiency and the liver (1994) (5)
Aspects of treatment in alpha 1-antitrypsin deficiency: insights derived from a Swedish PiZZ series. (1990) (5)
Biosynthesis of abnormally glycosylated alpha 1-antitrypsin by a human hepatoma cell line. (1984) (4)
Lack of association between hemochromatosis and alpha-antitrypsin deficiency. (1986) (4)
Wegener's granulomatosis in a patient with severe PiZZ alpha 1-antitrypsin deficiency. (1996) (4)
Hepatocyte inclusions of alpha 1-antichymotrypsin in a patient with partial deficiency of alpha 1-antichymotrypsin and chronic liver disease. (1990) (4)
The in vitro effect of lithocholic acid on the polymerization properties of PiZ alpha-1-antitrypsin. (1998) (4)
Proteases and protease inhibitors in chronic obstructive lung disease. (2009) (4)
Plasma alpha 1-antichymotrypsin in liver disease. (1985) (3)
Influence of Thyroid Hormone on the Formation of Bile Acids. (1956) (3)
Emphysema Before and After 1963 Historic Perspectives (2013) (3)
Procollagen type III peptide in asymptomatic children with alpha 1-antitrypsin deficiency. (1988) (2)
The Natural History of Air-flow Obstruction in PiZ Emphysema1–4 (2015) (2)
Serine proteinase inhibitors as acute phase reactants in liver disease. (1988) (2)
[Did Chopin suffer of antitrypsin deficiency? Lost autopsy protocol has caused frustration among physicians of our time in their attempts to confirm the diagnosis]. (2003) (2)
Liver Disease and Intermediate α1‐Antitrypsin Deficiency (2009) (2)
cal-Antichymotrypsin regulates Alzheimer f8-amyloid peptide fibril formation (2005) (2)
The N-terminal amino acid sequence from α1-antitrypsin isolated from liver inclusion bodies (1985) (2)
An interaction between Gemfibrozil and alpha1‐antitrypsin (1994) (1)
The N-terminal amino acid sequence from alpha 1-antitrypsin isolated from liver inclusion bodies. (1985) (1)
a,-Antitrypsin deficiency (1998) (1)
The serum sialyltransferase activity in alpha 1-antitrypsin deficiency. (1976) (1)
Letter: Role of sialystransferases in alpha-1-antitrypsin deficiency. (1975) (0)
Angiotensinogen in chronic liver disease. (1992) (0)
Emphysema before and after 1963. Historic perspectives. (1991) (0)
Hypo-αl-Antitrypsinämie (1964) (0)
Conformational changes of the alpha 1-proteinase inhibitor affecting its cholesterol binding ability. (1993) (0)
The Materials Science Graduate Days (2013) (0)
[A nation-wide cooperation is necessary for increased knowledge of alpha 1-antitrypsin deficiency]. (1990) (0)
[Necessity for an alpha 1-antitrypsin registry. The clinical follow-up of patients is easier]. (1994) (0)
The interaction of hydrophobic bile acids with the alpha 1-proteinase inhibitor. (1994) (0)
Complexes between proteinase 3, alpha-1-antitrypsin and proteinase 3 ANCA in Wegeners granulomatosis (1995) (0)
α1-Antitrypsin deficiency (1974) (0)
CYSTIC PITUITARY TUMOUR DEVELOPED FROM RATHKE'S CLEFT (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Sten G. Eriksson?

Sten G. Eriksson is affiliated with the following schools:

Lund University

Sten G. Eriksson's Academic­Influence.com Rankings

Why Is Sten G. Eriksson Influential?

Sten G. Eriksson's Published Works

Published Works

What Schools Are Affiliated With Sten G. Eriksson?

Sten G. Eriksson's AcademicInfluence.com Rankings